Effect of a new algorithm on blood transfusion during postpartum hemorrhage (PPH)

2013 ◽  
Vol 30 ◽  
pp. 175-175
Author(s):  
C. Chapellas ◽  
J. Cros ◽  
S. Ponsonnard ◽  
B. Youssef ◽  
P. Sengès ◽  
...  
Author(s):  
Aleksandra Polic ◽  
Tierra L. Curry ◽  
Judette M. Louis

Objective The study aimed to evaluate the impact of obesity on the management and outcomes of postpartum hemorrhage. Study Design We conducted a retrospective cohort study of women who delivered at a tertiary care center between February 1, 2013 and January 31, 2014 and experienced a postpartum hemorrhage. Charts were reviewed for clinical and sociodemographic data, and women were excluded if the medical record was incomplete. Hemorrhage-related severe morbidity indicators included blood transfusion, shock, renal failure, transfusion-related lung injury, cardiac arrest, and use of interventional radiology procedures. Obese (body mass index [BMI] ≥ 30 kg/m2) and nonobese women were compared. Data were analyzed using Chi-square, Student's t-test, Mann–Whitney U test, and linear regression where appropriate. The p-value <0.05 was significant. Results Of 9,890 deliveries, 2.6% (n = 262) were complicated by hemorrhage. Obese women were more likely to deliver by cesarean section (55.5 vs. 39.8%, p = 0.016), undergo a cesarean after labor (31.1 vs. 12.2%, p = 0.001), and have a higher quantitative blood loss (1,313 vs. 1,056 mL, p = 0.003). Both groups were equally likely to receive carboprost, methylergonovine, and misoprostol, but obese women were more likely to receive any uterotonic agent (95.7 vs. 88.9%, p = 0.007) and be moved to the operating room (32.3 vs. 20.4, p = 0.04). There was no difference in the use of intrauterine pressure balloon tamponade, interventional radiology, or decision to proceed with hysterectomy. The two groups were similar in time to stabilization. There was no difference in the need for blood transfusion. Obese women required more units of blood transfused (2.2 ± 2 vs. 2 ± 5 units, p = 0.023), were more likely to have any hemorrhage-related severe morbidity (34.1 vs. 25%, p = 0.016), and more than one hemorrhage related morbidity (17.1 vs. 7.9, p = 0.02). After controlling for confounding variables, quantitative blood loss, and not BMI was predictive of the need for transfusion. Conclusion Despite similar management, obese women were more likely to have severe morbidity and need more units of blood transfused. Key Points


2022 ◽  
Vol 226 (1) ◽  
pp. S281-S282
Author(s):  
Richard M. Burwick ◽  
Rachel A. Newman ◽  
Monica Rincon

2017 ◽  
Vol 32 (6) ◽  
pp. 879-882 ◽  
Author(s):  
Shohei Noguchi ◽  
Takeshi Murakoshi ◽  
Hiroko Konno ◽  
Mitsuru Matsushita ◽  
Minako Matsumoto

2019 ◽  
Vol 98 (4) ◽  
pp. 536-537
Author(s):  
Sarah Pont ◽  
Kathryn Austin ◽  
Ibinabo Ibiebele ◽  
Siranda Torvaldsen ◽  
Jillian Patterson ◽  
...  

2008 ◽  
Vol 30 (11) ◽  
pp. 1002-1007 ◽  
Author(s):  
Mrinalini Balki ◽  
Sudhir Dhumne ◽  
Shilpa Kasodekar ◽  
Jose C.A. Carvalho ◽  
Gareth Seaward

2021 ◽  
Author(s):  
Xianyan Lu ◽  
Tao Liu ◽  
Yan Zhou ◽  
Lili Qiu ◽  
Yimin Dai

Abstract Background: Blood loss as a percentage of total blood volume for redefining PPH may be more appropriate compared to the 500ml cutoff for every pregnant woman. This study is to investigate the value of body surface area in redefining PPH.Methods: In our prospective clinical observational study, we calculated the total blood volume using body surface area and measured blood loss at delivery using gravimetric and volumetric methods for all pregnant women included in our cohort (n=1715). For the five different body surface area groups, we determined different percentages of blood loss in total blood volume among 1201 participants. Furthermore, we compared the prediction values in blood transfusion based on the quantification of bleeding or proportion of blood loss in total blood volume at different quintiles among 514 severe PPH cases. Results: The median total blood volume and body surface area were 4639ml and 1.73 m2, respectively. The median total blood volume increased with increasing body surface area, and the different proportions of total blood volume increased accordingly. The median blood loss was 380ml and represented 8.28% of total blood volume. The median measured 24h blood loss across quintile 1 to 5 was 363ml, 360ml, 390ml, 380ml, 440ml, respectively. Using the definition with blood loss of 500 ml and 13% percentage of total blood volume, the incidence of PPH was 30% and 19%. However, the changes of the circulatory system secondary to obstetric hemorrhage was not significantly different at each quintile. Additionally, use of blood loss or the percentage of blood loss in total blood volume has high specificity and sensitivity as the indicators to predict blood transfusion.Conclusions: Our results suggest that blood loss exceeds 13% of total blood volume as a definition of postpartum hemorrhage. Blood loss above 30% of total blood volume may be recommended for blood transfusion.


2018 ◽  
Vol 37 (1) ◽  
pp. 19-24
Author(s):  
Nazneen Kabir ◽  
Begum Hosne Ara ◽  
Dilruba Akter ◽  
Tahmina Afrin Daisy ◽  
Sonia Jesmin ◽  
...  

Background: Postpartum hemorrhage (PPH) is a potentially life-threatening complication of both vaginal and caesarean delivery. The most frequent cause of postpartum hemorrhage is uterine atony, when the uterus fails to contract fully after delivery of the placenta. For the prevention of this uterine atony we need an effective uterotonic drug. Till now oxytocin is used for enhancing uterine contraction after delivery. But oxytocin has some limitations like shorter halflife, less contraction time and more side effects, whereas carbetocin has prolonged duration of action which ensures more contraction time and less adverse effects. So, carbetocin considered as a good alternative over oxytocin for the prevention of primary PPH in caesarean section. The Aim of Study: To see the efficacy and safety of carbetocin over oxytocin for the prevention of primary PPH during caesarean section. Patients and Methods: A randomized-controlled trial was conducted in the Institute of Child and Mother Health (ICMH), Dhaka, Bangladesh over a period of nine months from January to September 2016. Ninety-four patients who had got admitted in ICMH undergoing caesarean section at term were randomized into two groups receiving either 10IU oxytocin or 100μg carbetocin, after the operation. Outcome measures such as primary PPH, massive blood loss, need for additional uterotonic drug, additional blood transfusion as well as adverse effects were all documented. Results: This study had shown that carbetocin is superior in comparison to oxytocin for the prevention of primary PPH following caesarean section. Each patient obtained either a single dose of 100 microgram carbetocin intravenously or 10 IU of oxytocin during caesarean section. Massive blood loss occurred in 6.4%patients, blood transfusion needed in 17% patients and additional uterotonic needed for 25.5% patients in oxytocin group but in carbetocin group no massive blood loss occurred, only 2.1% patient needed immediate blood transfusion and no patient was required additional uterotonics. There were no major adverse effects observed in both the groups. No patients had developed PPH in carbetocin group. But 12.8% patients had developed primary PPH in oxytocin group. Conclusion: Carbetocin appears to be an effective new drug than oxytocin for the prevention of primary postpartum hemorrhage in caesarean section. J Bangladesh Coll Phys Surg 2019; 37(1): 19-24  


Sign in / Sign up

Export Citation Format

Share Document